Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918940 | Radiotherapy and Oncology | 2012 | 4 Pages |
Abstract
SBRT for patients with MPLC appears to be a safe and effective local treatment alternative to surgery, particularly for medically inoperable patients. Patients with metachronous MPLC have encouraging survival rates, and thus local therapy appears justified. However, patients with synchronous MPLC have poor OS and PFS despite having excellent local control, and thus the utility of local therapy in this population requires further study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kimberly M. Creach, Jeffrey D. Bradley, Pawinee Mahasittiwat, Clifford G. Robinson,